Man Group plc Buys New Shares in Viemed Healthcare, Inc. $VMD

Man Group plc bought a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) during the second quarter, HoldingsChannel reports. The firm bought 94,088 shares of the company’s stock, valued at approximately $1,073,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kemnay Advisory Services Inc. acquired a new position in Viemed Healthcare in the 4th quarter valued at approximately $46,000. Quarry LP acquired a new stake in shares of Viemed Healthcare during the 3rd quarter worth approximately $48,000. Globeflex Capital L P acquired a new stake in shares of Viemed Healthcare during the 2nd quarter worth approximately $86,000. AQR Capital Management LLC bought a new stake in shares of Viemed Healthcare during the first quarter valued at approximately $90,000. Finally, Legal & General Group Plc acquired a new position in shares of Viemed Healthcare in the second quarter valued at $97,000. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Stock Up 2.0%

VMD opened at $8.98 on Thursday. The firm has a market cap of $342.05 million, a price-to-earnings ratio of 24.95, a PEG ratio of 2.17 and a beta of 1.09. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.02 and a current ratio of 1.13. The firm’s 50-day simple moving average is $10.70 and its 200-day simple moving average is $9.91. Viemed Healthcare, Inc. has a twelve month low of $6.05 and a twelve month high of $12.61.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.05). The firm had revenue of $78.10 million for the quarter, compared to the consensus estimate of $78.00 million. Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. Equities research analysts anticipate that Viemed Healthcare, Inc. will post 0.41 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently commented on VMD shares. Weiss Ratings cut Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, August 17th. Freedom Capital cut shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Barrington Research initiated coverage on shares of Viemed Healthcare in a report on Monday, August 24th. They set an “outperform” rating and a $14.00 price objective for the company. Finally, Wall Street Zen lowered shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $14.00.

Insider Activity at Viemed Healthcare

In other news, Director Timothy Smokoff sold 20,000 shares of Viemed Healthcare stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the completion of the transaction, the director owned 75,518 shares in the company, valued at approximately $868,457. The trade was a 20.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider William Frazier sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total value of $117,200.00. Following the completion of the transaction, the insider directly owned 73,214 shares in the company, valued at $858,068.08. The trade was a 12.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 20.60% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.